Canada News Beep | NewsBeep.com
  • News Beep
  • Canada
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology
Canada News Beep | NewsBeep.com
Canada News Beep | NewsBeep.com
  • News Beep
  • Canada
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology

Browsing Tag

Medical Pharmaceuticals

22 posts
HHealthcare
Apotex becomes the first Canadian‑based pharmaceutical company to receive Health Canada approval for a generic equivalent of Ozempic®
Read More

Apotex becomes the first Canadian‑based pharmaceutical company to receive Health Canada approval for a generic equivalent of Ozempic®

  • May 4, 2026
TORONTO, May 1, 2026 /PRNewswire/ – Apotex Inc. (“Apotex” or the “Company”), Canada’s largest Canadian‑based global health company,…
HHealthcare
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies
Read More

Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies

  • April 20, 2026
Kelonia’s lead program, KLN-1010, is a potentially first-in-class lentiviral in vivo CAR-T therapy currently in Phase 1 for…
HHealth
Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance
Read More

Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance

  • December 12, 2025
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 12, 2025 /CNW/ — USANewsGroup.com News Commentary – Scientists developed an…
HHealth
1 Ranked Institute, IIT Madras & Danish University Study reveals Genetic 'Switches' that can transform Disease Research
Read More

1 Ranked Institute, IIT Madras & Danish University Study reveals Genetic ‘Switches’ that can transform Disease Research

  • October 8, 2025
CHENNAI, India, Oct. 8, 2025 /CNW/ — India’s No:1 Ranked Institute, the Indian Institute of Technology Madras, and…
HHealthcare
AAOS Updates Clinical Practice Guideline for the Management of Rotator Cuff Injuries
Read More

AAOS Updates Clinical Practice Guideline for the Management of Rotator Cuff Injuries

  • August 29, 2025
Updated guideline based on the latest evidence-based recommendations ROSEMONT, Ill., Aug. 28, 2025 /PRNewswire/ — The American Academy…
HHealthcare
Leal Therapeutics Announces $30 Million Series A to Progress First-In-Class Neuro-Metabolic Therapies for Neurodegenerative and Neuropsychiatric Disorders with High-Unmet Need
Read More

Leal Therapeutics Announces $30 Million Series A to Progress First-In-Class Neuro-Metabolic Therapies for Neurodegenerative and Neuropsychiatric Disorders with High-Unmet Need

  • August 29, 2025
Leal Therapeutics is developing first-in-class therapeutics to correct metabolic imbalances in the brain for treatment of high unmet…
GGenetics
Ultima Genomics and Gene by Gene Partner to Expand Global Access to High-Quality, Low-Cost Sequencing on the UG 100™ Platform
Read More

Ultima Genomics and Gene by Gene Partner to Expand Global Access to High-Quality, Low-Cost Sequencing on the UG 100™ Platform

  • August 19, 2025
Collaboration Extends Global Reach of High-Performance Genomic Sequencing on the UG 100™ Platform FREMONT, Calif. and HOUSTON, Aug.…
HHealthcare
Novo Nordisk lowers cost of Ozempic® to $499 per month for self-paying patients, in support of patient access to authentic, FDA-approved semaglutide medicines
Read More

Novo Nordisk lowers cost of Ozempic® to $499 per month for self-paying patients, in support of patient access to authentic, FDA-approved semaglutide medicines

  • August 19, 2025
Ozempic® is the GLP-1 with the most FDA-approved uses for patients with type 2 diabetes including, improvement of…
HHealthcare
Izalontamab Brengitecan (EGFRxHER3 ADC) Granted Breakthrough Therapy Designation by U.S. FDA for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
Read More

Izalontamab Brengitecan (EGFRxHER3 ADC) Granted Breakthrough Therapy Designation by U.S. FDA for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer

  • August 18, 2025
First Breakthrough Therapy Designation in the U.S. for SystImmune and Bristol Myers Squibb’s Izalontamab brengitecan (Iza-bren) based on data…
HHealth
Genome BC Funds Research into the Respiratory Fallout of Wildfires
Read More

Genome BC Funds Research into the Respiratory Fallout of Wildfires

  • August 6, 2025
VANCOUVER, BC, Aug. 6, 2025 /CNW/ – British Columbians know the stark realities of climate change, as wildfires…
Canada News Beep | NewsBeep.com
www.newsbeep.com